- Home
- CADL vs TPVG Comparison
CADL vs TPVG Comparison
Compare CADL & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- TPVG
- Stock Information
- Founded
- CADL 1999
- TPVG 2013
- Country
- CADL United States
- TPVG United States
- Employees
- CADL N/A
- TPVG N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- TPVG Other Consumer Services
- Sector
- CADL Health Care
- TPVG Consumer Discretionary
- Exchange
- CADL Nasdaq
- TPVG Nasdaq
- Market Cap
- CADL 306.4M
- TPVG 296.2M
- IPO Year
- CADL 2021
- TPVG N/A
- Fundamental
- Price
- CADL $8.75
- TPVG $7.38
- Analyst Decision
- CADL Strong Buy
- TPVG Hold
- Analyst Count
- CADL 4
- TPVG 6
- Target Price
- CADL $21.00
- TPVG $7.75
- AVG Volume (30 Days)
- CADL 1.4M
- TPVG 324.2K
- Earning Date
- CADL 03-13-2025
- TPVG 03-05-2025
- Dividend Yield
- CADL N/A
- TPVG 16.26%
- EPS Growth
- CADL N/A
- TPVG N/A
- EPS
- CADL N/A
- TPVG 0.82
- Revenue
- CADL N/A
- TPVG $108,208,000.00
- Revenue This Year
- CADL N/A
- TPVG N/A
- Revenue Next Year
- CADL N/A
- TPVG $0.42
- P/E Ratio
- CADL N/A
- TPVG $9.00
- Revenue Growth
- CADL N/A
- TPVG N/A
- 52 Week Low
- CADL $1.34
- TPVG $6.44
- 52 Week High
- CADL $14.60
- TPVG $9.73
- Technical
- Relative Strength Index (RSI)
- CADL 52.73
- TPVG 39.76
- Support Level
- CADL $7.65
- TPVG $7.25
- Resistance Level
- CADL $8.31
- TPVG $7.66
- Average True Range (ATR)
- CADL 0.92
- TPVG 0.20
- MACD
- CADL -0.10
- TPVG -0.07
- Stochastic Oscillator
- CADL 33.33
- TPVG 22.64
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.